Anti-NMDAR autoimmune encephalitis.

Explore this paper's citation graph

Summary

About half of these patients improved with immunotherapy including high-dose intravenous corticosteroids and intravenous immunoglobulins is administrated to these patients, but the patients who had no improvement with these therapy require further treatments with rituximab or cyclophosphamide.

Type
review
Published
2014-09-01
Cited by
70
References
55

Keywords

Encephalitis, Medicine, NMDA receptor, Autoantibody, Immunology

References

Cited by

Related papers